hero section gradient
14 handpicked stocks

Political Donors: Team Blue

This collection features influential corporations whose employees and PACs heavily support Democratic campaigns and causes. Our analysts have carefully selected these stocks based on their consistent political giving patterns and potential to benefit from Democratic policy priorities.

Author avatar

Han Tan | Market Analyst

Published on June 17

Your Basket's Financial Footprint

Summary and investor key takeaways based on the provided basket market capitalisation data.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility and more stable returns, likely tracking broad-market moves.
  • Best used as a core holding for diversified portfolios rather than a speculative, high-growth position.
  • Expect steady, long-term appreciation; short-term explosive gains are unlikely and not guaranteed.
Total Market Cap
  • GOOG: $3.03T

  • MSFT: $3.85T

  • AMZN: $2.37T

  • Other

About This Group of Stocks

1

Our Expert Thinking

This collection focuses on companies with strong Democratic donation histories whose business interests often align with the party's policy objectives. We believe these companies may be strategically positioned to benefit from a favorable regulatory environment when Democratic policies are enacted.

2

What You Need to Know

These stocks primarily represent large-cap growth opportunities in influential sectors like technology, media, and entertainment. Their performance may be influenced by election cycles and political shifts, making them an interesting thematic investment during campaign seasons.

3

Why These Stocks

Each company was selected through data-driven analysis of Federal Election Commission records, identifying businesses with consistent patterns of Democratic-leaning donations. These companies represent industry leaders whose political contributions reflect a clear alignment.

Why You'll Want to Watch These Stocks

🗳️

Election Cycle Timing

With major elections approaching, these companies could see policy tailwinds if Democratic candidates perform well, potentially boosting their market performance.

💼

Tech and Media Powerhouses

This collection includes some of the most influential companies in technology and entertainment, sectors that often benefit from Democratic policy priorities.

📊

Data-Driven Selection

Each company was chosen based on actual Federal Election Commission data, not opinions, ensuring an authentic representation of corporate political alignment.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions